Rachel Sachs, DO
Sports Medicine · Kansas City, MONPI 1497138663
Payments from drug & device makers
Across 15 payments — averaging $111.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Titan Surgical Group, LLC$1K
- Pacira Therapeutics, Inc.$315
- Organon$38
- Johnson & Johnson$38
- Electronic Waveform Lab, Inc.$24
- Sumitomo Pharma America, Inc.$19
- plus $45 from 3 others
What the payments were for
- Food & beverage$47829%
- Education$1,20071%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Titan Surgical Group, LLC | 1 | $1,200 |
| Pacira Therapeutics, Inc. | 5 | $315 |
| Organon | 1 | $38 |
| Johnson & Johnson | 3 | $38 |
| Electronic Waveform Lab, Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Bioventus LLC | 1 | $15 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zilretta$248
How this compares
$1,678 in reported general payments places this provider in the 45th percentile of 127 sports medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 11 | $20,459 |
| Sertraline Hcl | 11 | $898 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $469 |
| Chlorthalidone | 18 | $284 |
| Atorvastatin Calcium | 49 | $269 |
| Gabapentin | 14 | $263 |
| Pantoprazole Sodium | 17 | $191 |
| Potassium Chloride | 21 | $164 |
| Fluticasone Propionate | 13 | $158 |
| Cyclobenzaprine Hcl | 14 | $157 |
| Metformin Hcl | 20 | $149 |
| Lisinopril | 24 | $135 |
| Escitalopram Oxalate | 19 | $134 |
| Levothyroxine Sodium | 19 | $117 |
| Losartan Potassium | 21 | $66 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Kansas City
- Scott LuallinKansas City$1.2M
- Richard SchwendKansas City$17K
- Christopher ShawKansas City$10K
- Kevin GrayKansas City$4K
- Margaret GibsonKansas City$2K
- Larkin WadsworthSaint Louis$30.1M
- Kristin OliverColumbia$209K
- Clayton NuelleColumbia$138K
- Christopher RothrockSaint Louis$111K
- Jason ShellhaasSaint Louis$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.